Latest News

CHINA YUCHAI INTERNATIONAL TO ANNOUNCE UNAUDITED 2025 FIRST-HALF YEAR FINANCIAL RESULTS ON AUGUST 8, 2025

- Earnings Call to Begin at 8:00 A.M. EDT – SINGAPORE, July 28, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), announced today that it will be releasing its 2025 unaudited first-half year financial results onFriday, August 8, 2025 before t...

2025-07-28 19:45 5463

Daqo New Energy Issues Its 2024 Environmental, Social and Governance (ESG) Report

SHANGHAI, July 28, 2025 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today published its 2024 Environmental, Social and Governance ("ESG") report.  The 2024 ESG rep...

2025-07-28 19:00 3299

2025 World Internet Conference Digital Silk Road Development Forum Opens in Quanzhou

QUANZHOU, China, July 28, 2025 /PRNewswire/ -- A news report from CRI Online: The opening ceremony of the Digital Silk Road Development Forum of the 2025 World Internet Conference O...

2025-07-28 18:45 2238

Quhuo Partners with NIU World to Launch Innovative Fresh Beef Chain Brand Incubation Platform, Accelerating the Transformation of China's Fresh Beef Consumption Market

BEIJING, July 28, 2025 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"), a leading tech-enabled service platform, today announced a strategic partnership with NIU World, a local food group inChina, to jointly establish a new chain brand incubation platform focused on fresh be...

2025-07-28 18:00 2871

Caliway Announces FDA Clearance of IND Application for CBL-514 to Proceed with SUPREME-01, the First Global Pivotal Phase 3 Study for Reducing Abdominal Subcutaneous Fat

* CBL-514, Caliway's first-in-class lipolysis drug candidate, has been granted clearance from the U.S. FDA to proceed with SUPREME-01, a global, multicenter, pivotal Phase 3 study. Subject recruitment is expected to begin in the U.S. andCanada in Q3 2025. * CBL-514 is the first 505(b)(1) inve...

2025-07-28 17:51 3526

FinVolution Group Publishes Seventh Annual ESG Report

SHANGHAI, July 28, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform, today announced it has released its 2024 Environmental, Social, and Governance (ESG) report, the Company's seventh consecutive annual ESG report. The report provid...

2025-07-28 17:30 2726

Cheetah Mobile to Acquire Controlling Stake in UFACTORY to Accelerate Its Robotics Commercialization Strategy

BEIJING, July 28, 2025 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), aChina-based IT company, today announced that one of its majority-owned subsidiaries has signed a definitive agreement to acquire an equity interest of 60.8% in Shenzhen UFACTORY Technolog...

2025-07-28 17:00 3308

Last Chance to Get COSRX's Best-Selling Snail Duo on the House at Alfred Coffee -- This Wednesday Only

LOS ANGELES, July 28, 2025 /PRNewswire/ -- It's the glow-up everyone's been talking about. This July, cult K-beauty favoriteCOSRX joined forces with LA's iconic café Alfred Coffee ...

2025-07-28 16:49 2482

Doosan Robotics Accelerates Push to Become an AI Robot Solutions Leader

— Acquires 89.59% stake in U.S. automation engineering firm ONExia — Strengthens future growth engine with AI•humanoid technology•top-tier talent and builds an R&D Innovation center EXTON, Pa. and SEONGNAM, South Korea, July 28, 2025 /PRNewswire/ -- Doosan Robotics is stepping up its transformati...

2025-07-28 16:10 2424

Beijing Review: The Across the Pacific: China-U.S. Youth Dialogue for a Shared Future program concluded in Shanghai.

BEIJING, July 28, 2025 /PRNewswire/ -- On July 22, the Across the Pacific: China-U.S. Youth Dialogue for a Shared Future program officially came to a close inShanghai.   The story never ends! On July 22, the Across the Pacific: China-#US Youth Dialogue for a Shared Future pr...

2025-07-28 15:45 2158

The 2025 China-ASEAN Education Cooperation Week Held in Guizhou

GUIYANG, China, July 28, 2025 /PRNewswire/ -- This is a report from Discover Guizhou: On July 26, the opening ceremony of the 2025 China-ASEAN Education Cooperation Week (CAECW) was held at the permanent venue of the China-ASEAN Education Cooperation Week in Gui'an New Area,Guiyang, Guizhou. The...

2025-07-28 15:28 1972

Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'

* CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing EYLUXVI® to the reference product Eylea® * Upon approval, EYLUXVI® will be Alteogen's second biosimilar product, following a Herceptin® biosimilar by Alteogen's license partner Qilu Pharm...

2025-07-28 14:00 3345

DIGITIMES ASIA: Nvidia explores SOCAMM deployment for next-gen AI systems

TAIPEI, July 23, 2025 /PRNewswire/ -- Nvidia is preparing to enter a new phase in the memory market by planning to deploy between 600,000 and 800,000 SOCAMM modules in 2025. This initiative positions SOCAMM as a potential successor to high-bandwidth memory (HBM). Although the initial deployment v...

2025-07-28 13:02 3994

NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer

HONG KONG, July 28, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the National Medical Products Administration (NMPA) has accepted the supplementary New Drug Application (sNDA) for ivonescimab (PD-1/VEGF bispecific antibody) in combination with ...

2025-07-28 12:14 3939

Ascletis Announces First Participants with Obesity or Overweight Dosed in Its U.S. 12-week Phase IIa Study Evaluating Once-Monthly Subcutaneous Depot Formulation of Small Molecule GLP-1R Agonist ASC30

-          First participants with obesity or overweight with at least one w eight-related comorbidity have been dosed in a U.S. 12-week Phase IIa study with once-monthly subcutaneous (SQ) depot formulation of small molecule GLP-1  receptor agonist ASC30. -          Ultra-long-acting SQ depot for...

2025-07-28 08:15 2498

Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2025 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a positive prof...

2025-07-28 08:11 2724

Breakthrough in Light Therapy: KouShiCare utilizes DWV™LLLT Technology to Treat Dry Eyes

HONG KONG, July 27, 2025 /PRNewswire/ -- KouShiCare, a leading innovator in healthcare technology, is proud to announce a groundbreaking advancement in the treatment of dry eye disease. The company's latest device harnesses the power of DWV™ Low-Level Laser Therapy (LLLT) technology, marking a si...

2025-07-27 23:07 3762

New Yorkers immerse in incredible Shanghai culture

SHANGHAI, July 27, 2025 /PRNewswire/ -- A news report from  english.shanghai.gov.cn Shanghai Day at Lincoln Center kicks off with a family-frien...

2025-07-27 23:06 3020

Global Times: How 'investing in the people' benefits the whole society in China

BEIJING, July 27, 2025 /PRNewswire/ -- Recently, many friends and I purchased new home appliances. Statistics show that more than 100 million home appliances have been replaced through the consumer goods trade-in program this year. With generous subsidies fueling a consumption boom, could this be...

2025-07-27 23:04 2478

To advance China-US trade ties with sincerity, principles: Global Times

BEIJING, July 27, 2025 /PRNewswire/ -- A new round of China-US economic and trade talks is set to be held inSweden from Sunday to Wednesday. This follows a series of significant consensuses reached inGeneva and the establishment of a framework during talks inLondon. At a time when the global econ...

2025-07-27 22:40 2435

Week's Top Stories